Klor-con and Accuneb drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Klor-con (potassium chloride) and Accuneb (albuterol sulfate). Common drug interactions include dysphonia among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Klor-con and Accuneb. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Accuneb?

Accuneb has active ingredients of albuterol sulfate. eHealthMe is studying from 189 Accuneb users. Check the latest studies of Accuneb.



On Jul, 31, 2026

15 people who take Klor-con and Accuneb together, and have interactions are studied.

Klor-con and Accuneb drug interactions.

What are the common drug interactions of Klor-Con and Accuneb, by gender? *:

female:

  1. Dysphonia (speech disorder attributable to a disorder of phonation)
  2. Pneumonia
  3. Bradycardia (abnormally slow heart action)
  4. Cardiac failure acute
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Cough
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Viral upper respiratory tract infection
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Acute myocardial infarction (acute heart attack)

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Cardiac failure
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Melaena (the passage of black, tarry stools)
  5. Dementia (madness)
  6. Fall
  7. Hallucination, visual (seeing things that aren't there)
  8. Hip fracture
  9. Memory impairment
  10. Parkinson's disease

What are the common drug interactions of Klor-Con and Accuneb, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Acute myocardial infarction (acute heart attack)
  2. Back disorder
  3. Blood triglycerides increased
  4. Cyst (a closed sac)
  5. Cystitis bacterial (inflammation of the wall of the bladder by bacteria escherichia coli)
  6. Dermal cyst
  7. Diabetes mellitus inadequate control
  8. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  9. Fatigue (feeling of tiredness)
  10. Gastrointestinal bacterial infection (infection of the stomach and intestines caused by bacteria)

60+:

  1. Dysphonia (speech disorder attributable to a disorder of phonation)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Hallucination, visual (seeing things that aren't there)
  4. Hip fracture
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Memory impairment
  7. Parkinson's disease
  8. Viral upper respiratory tract infection
  9. Body height decreased
  10. Cardiac disorder

What are the existing conditions these people have? *

  1. Wheezing (a high-pitched whistling sound made while you breath): 9 people, 60.00%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 26.67%
  3. Dyspnea (difficult or laboured breathing): 4 people, 26.67%
  4. Muscle Spasms (muscle contraction): 3 people, 20.00%
  5. Cardiac Failure Congestive: 3 people, 20.00%
  6. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 20.00%
  7. Gastrointestinal Arteriovenous Malformation (malformation of arteries and veins in gastrointestinal tract): 3 people, 20.00%
  8. High Blood Cholesterol: 3 people, 20.00%
  9. Pain: 3 people, 20.00%
  10. Diarrhea: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and Accuneb?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Klor-con and Accuneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Accuneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Klor-con and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Accuneb and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride and albuterol sulfate (the active ingredients of Klor-con and Accuneb, respectively), and Klor-con and Accuneb (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: